These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9195490)

  • 1. Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells.
    Satoh E; Naganuma H; Sasaki A; Nagasaka M; Ogata H; Nukui H
    J Neurooncol; 1997 Jul; 33(3):195-200. PubMed ID: 9195490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of transforming growth factor-beta secretion from malignant glioma cells by interleukin-1 beta.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Nukui H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):145-50. PubMed ID: 8869149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Nagasaka M; Isoe S; Nakano S; Nukui H
    Neurol Med Chir (Tokyo); 1995 Jul; 35(7):423-30. PubMed ID: 7477684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Kawataki T; Amagasaki K; Nukui H
    Neurol Med Chir (Tokyo); 2001 May; 41(5):253-8; discussion 258-9. PubMed ID: 11396305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
    Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
    Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta inhibits interferon-gamma secretion by lymphokine-activated killer cells stimulated with tumor cells.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Tasaka K; Nukui H
    Neurol Med Chir (Tokyo); 1996 Nov; 36(11):789-95. PubMed ID: 9420430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Tasaka K; Nukui H
    Jpn J Cancer Res; 1994 Sep; 85(9):952-7. PubMed ID: 7961125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
    Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
    Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased migration of a human glioma cell line after in vitro CyberKnife irradiation.
    Canazza A; Calatozzolo C; Fumagalli L; Bergantin A; Ghielmetti F; Fariselli L; Croci D; Salmaggi A; Ciusani E
    Cancer Biol Ther; 2011 Oct; 12(7):629-33. PubMed ID: 21775821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.
    Tabatabai G; Frank B; Möhle R; Weller M; Wick W
    Brain; 2006 Sep; 129(Pt 9):2426-35. PubMed ID: 16835250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases.
    Leitlein J; Aulwurm S; Waltereit R; Naumann U; Wagenknecht B; Garten W; Weller M; Platten M
    J Immunol; 2001 Jun; 166(12):7238-43. PubMed ID: 11390472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion.
    Kurimoto M; Endo S; Arai K; Horie Y; Nogami K; Takaku A
    J Neurooncol; 1994; 22(1):33-44. PubMed ID: 7714549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved bioassay for the detection of transforming growth factor-beta 1 and beta 2 in malignant gliomas.
    Naganuma H; Sasaki A; Satoh E; Sakihama T; Tasaka K; Nukui H
    Neurol Med Chir (Tokyo); 1994 Mar; 34(3):143-9. PubMed ID: 7516043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioblastoma cell derived transforming growth factor-beta 2: evidence for secretion of both high and low molecular weight biologically active forms.
    Bodmer S; Huber D; Heid I; Fontana A
    J Neuroimmunol; 1991 Oct; 34(1):33-42. PubMed ID: 1894732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.
    Yamada N; Kato M; Yamashita H; Nistér M; Miyazono K; Heldin CH; Funa K
    Int J Cancer; 1995 Aug; 62(4):386-92. PubMed ID: 7635563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
    Huber D; Philipp J; Fontana A
    J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.